CLINICAL_TRIALS
research
· 2025-11-18
Clinical Trial Update: Cabergoline for Episodic Migraine [Phase 2]
Summary
A Phase 2 clinical trial evaluating cabergoline for episodic migraine is currently recruiting at Aarhus University Hospital.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aarhus University Hospital | Conditions: Migraine | Phase 2 | Status: RECRUITING